Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.

NCT06550687 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

All Types of Metastatic Solid Malignancy
1st-line Treatment
Exome Analysis
Active File EXOMA2 Study

Interventions

OTHER: Cancer patients' preferences regarding genetic information modalities prior to theranostic exome analysis

Sponsor

Centre Georges Francois Leclerc